The Toronto Blue Jays are at it again, making moves that will have fans talking and analysts scrambling for their hot takes. This time, they’re bringing in a 30-year-old right-hander with something to prove. A former first-round pick, he’s battled injuries and inconsistency—but Toronto clearly sees something others might have missed. Buckle up, because this could get interesting.

The Blue Jays really want to be the center of attention, don’t they? First, the negotiations with Vladimir Guerrero Jr., and now they want to sign Dillon Tate. They are pulling off some moves, but are the moves really any help to the team?  It is not official, but it looks like Dillon Tate is returning to the Blue Jays. This news was reported by Arden Zwelling, and he says that all that is pending is the physical exam. This news has the fan base in frenzy mode, but this deal is not as easy as it sounds.

The Blue Jays will have to clear some space to fill in Tate. With some pitchers like Alek Manoah and Angel Bastardo recovering, they are likely to be shifted to 60-day IL to fit in Dillon Tate. The Blue Jays originally claimed him off waivers last September, and he did make 4 starts with the team in 2024 with an ERA of 5.40. The main reason many people are surprised is because of the injury and performance issues Tate has had. Tate suffered a nightmare injury to his right forearm flexor, and being a right-handed pitcher, his 2023 season was over.

This injury raises a lot of questions on his durability, especially with him not growing any younger. However, this is not the only problem, Tate’s performance has seen a decline during the recent seasons. In the 2022 season, he had an ERA of 3.05, which looks decent but is not. He was giving away 2 walks every 9 innings and had 7.3 K/9. This is below average for a relief pitcher. This shows that his control of the mound and over the plate is very questionable.

With him having missed a whole season, the fans and insiders are questioning his effectiveness. We know if Tate is 100%, he is unstoppable, but with an injury-hit pitching lineup, can the Blue Jays really bet on him to shake off all the rust and return to his best? The Blue Jays are clearly willing to roll the dice on Tate, but whether this bet pays off is another story. Banking on a pitcher fresh off a lost season and declining stats isn’t exactly a blueprint for dominance. If he rebounds, it’s a steal—if not, well, at least Toronto will have another name to add to its growing list of “what-if” signings.

Max Scherzer has the Blue Jays fans reeling after his spring heroics

Max Scherzer doesn’t do mediocrity—he does dominance, intensity, and the kind of performances that make fans lose their minds. At 40, he’s still out there, proving that age is just another number on the stat sheet. Toronto wanted an ace, and they got a future Hall of Famer who isn’t here for nostalgia—he’s here to deal. This is exactly what a fully healthy Max Scherzer can do. Scherzer has the Blue Jay fans in awe after his recent performance. As the 2025 spring training goes on, Max Scherzer has stepped up for the Jays in a big way.

In the 9 innings he has pitched so far, Scherzer has 14 strikeouts with an ERA of 2. This performance has earned him praise from all the insiders and even his teammates, like Vladimir Guerrero Jr. The Blue Jays manager John Schneider was also impressed, saying, “He’s got a variety of different ways to do it. He reads hitters really well. I think him and Kirky (Alejandro Kirk) are getting closer and closer to being really good on the same page.” With his experience and intelligence, the Blue Jays can make a real push for the postseason.

If this is what Scherzer looks like in spring, imagine the chaos he’ll bring when the games actually matter. Toronto wanted a workhorse, and they might have just unleashed a bulldog. If he stays healthy, the AL better brace itself—because Max Scherzer isn’t here to ease into retirement; he’s here to dominate.